Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-/- mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 6, 2011, Pages 1260-1267

  Wu, Dalei ^a   Nishimura, Noriko ^b   Kuo, Victoria ^a   Fiehn, Oliver ^c   Shahbaz, Sevini ^c   Van Winkle, Laura ^a   Matsumura, Fumio ^a   Vogel, Christoph Adam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^c NONE

Author keywords

AhR; atherosclerosis; macrophages

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; APOLIPOPROTEIN E; AROMATIC HYDROCARBON; CHEMOKINE; INTERLEUKIN 8; MACROPHAGE ELASTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; GENETIC ASSOCIATION; IN VITRO STUDY; INFLAMMATION; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULITIS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; CYTOCHROME P-450 CYP1A1; HUMANS; INTERLEUKIN-8; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED C57BL; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, INTERLEUKIN-8B; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TOBACCO; U937 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULITIS;

EID: 79957489926     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.220202     Document Type: Article

References (41)

1. Bertazzi PA, Bernucci I, Brambilla G, Consonni D, Pesatori AC. The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ Health Perspect. 1998;106(suppl 2):625-633. (Pubitemid 28256770)
2. Pelclova D, Fenclova Z, Preiss J, Prochazka B, Spacil J, Dubska Z, Okrouhlik B, Lukas E, Urban P. Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8-tetrachlordibenzop-dioxin. Int Arch Occup Environ Health. 2002;75(suppl):S60-S66. (Pubitemid 36075166)
3. Brewster DW, Matsumura F, Akera T. Effects of 2,3,7,8-tetrachlorodibenzo- p-dioxin on guinea pig heart muscle. Toxicol Appl Pharmacol. 1987;89:408-417. (Pubitemid 17101959)
4. Arsenescu V, Arsenescu RI, King V, Swanson H, Cassis LA. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect. 2008;116:761-768. (Pubitemid 351943932)
5. Flesch-Janys D, Berger J, Gurn P, Manz A, Nagel S, Waltsgott H, Dwyer JH. Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am J Epidemiol. 1995;142: 1165-1175. (Pubitemid 26466657)
6. Bombick DW, Matsumura F, Madhukar BV. TCDD (2,3,7,8-tetrachlorodibenzo-p- dioxin) causes reduction in the low density lipoprotein (LDL) receptor activities in the hepatic plasma membrane of the guinea pig and rat. Biochem Biophys Res Commun. 1984;118:548-554. (Pubitemid 14194765)
7. Dalton TP, Kerzee JK, Wang B, Miller M, Dieter MZ, Lorenz JN, Shertzer HG, Nerbert DW, Puga A. Dioxin exposure is an environmental risk factor for ischemic heart disease. Cardiovasc Toxicol. 2001;1: 285-298.
8. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
9. Vogel CF, Sciullo E, Matsumura F. Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation. Cardiovasc Toxicol. 2004;4:363-373. (Pubitemid 39552105)
10. Vogel CF, Sciullo E, Wong P, Kuzmicky P, Kado N, Matsumura F. Induction of proinflammatory cytokines and C-reactive protein in human macrophage cell line U937 exposed to air pollution particulates. Environ Health Perspect. 2005;113:1536-1541. (Pubitemid 41614908)
11. Shin WS, Szuba A, Rockson SG. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis. 2002;160:91-102. (Pubitemid 34076646)
12. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem. 1996;271: 8837-8842. (Pubitemid 26123306)
13. Vogel CF, Sciullo E, Li W, Wong P, Lazennec G, Matsumura F. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol. 2007;21:2941-2955. (Pubitemid 350223506)
14. Gargalovic PS, Imura M, Zhang B, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Patel S, Nelson SF, Horvath S, Berliner JA, Kirchgessner TG, Lusis AJ. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci USA. 2006;103:12741-12746. (Pubitemid 44298631)
15. Boisvert WA, Rose DM, Johnson KA, Fuentes ME, Lira SA, Curtiss LK, Terkeltaub RA. Up-regulated expression of the CXCR2 ligand KC/GRO- in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol. 2006;168:1385-1395.
16. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest. 1998;101:353-363. (Pubitemid 28067332)
17. Papadopoulou C, Corrigall V, Taylor PR, Poston RN. The role of the chemokines MCP-1, GRO-, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques. Cytokine. 2008;43: 181-186.
18. Yang G, Rosen DG, Liu G, Yang F, Guo X, Xiao X, Xue F, Mercado-Uribe I, Huang J, Lin SH, Mills GB, Liu J. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res. 2010;16:3875-3886.
19. Taegue S, Pinkerton K, Goldsmit M, Gebremichael A, Chang S, Jenkins R, Moneyhun J. Sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhal Toxicol. 1994;6: 79-93. (Pubitemid 2051383)
20. Huster D, Purnat TD, Burkhead JL, Ralle M, Fiehn O, Stuckert F, Olson NE, Teupser D, Lutsenko S. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem. 2007;282:8343-8355. (Pubitemid 47093558)
21. Kasai A, Hiramatsu N, Hayakawa K, Yao J, Maeda S, Kitamura M. High levels of dioxin-like potential in cigarette smoke evidenced by in vitro and in vivo biosensing. Cancer Res. 2006;66:7143-7150. (Pubitemid 44197692)
22. Kitamura M, Kasai A. Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway. Cancer Lett. 2007;252:184-194. (Pubitemid 46809788)
23. Matsumoto S, Kobayashi T, Katoh M, Saito S, Ikeda Y, Kobori M, Masuho Y, Watanabe T. Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development. Am J Pathol. 1998;153:109-119. (Pubitemid 28317513)
24. Brodmerkel CM, Huber R, Covington M, Diamond S, Hall L, Collins R, Leffet L, Gallagher K, Feldman P, Collier P, Stow M, Gu X, Baribaud F, Shin N, Thomas B, Burn T, Hollis G, Yeleswaram S, Solomon K, Friedman S, Wang A, Xue CB, Newton RC, Scherle P, Vaddi K. Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J Immunol. 2005;175:5370-5378. (Pubitemid 41456423)
25. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, Sarau HM. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem. 1998;273: 10095-10098. (Pubitemid 28227606)
26. Nazarenko DA, Dertinger SD, Gasiewicz TA. In vivo antagonism of AhR-mediated gene induction by 3′-methoxy-4′-nitroflavone in TCDDresponsive lacZ mice. Toxicol Sci. 2001;61:256-264. (Pubitemid 32499393)
27. Kim SH, Henry EC, Kim DK, Kim YH, Shin KJ, Han MS, Lee TG, Kang JK, Gasiewicz TA, Ryu SH, Suh PG. Novel compound 2-methyl-2Hpyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol. 2006;69:1871-1878. (Pubitemid 43894303)
28. Podechard N, Le Ferrec E, Rebillard A, Fardel O, Lecureur V. NPC1 repression contributes to lipid accumulation in human macrophages exposed to environmental aryl hydrocarbons. Cardiovasc Res. 2009;82: 361-370.
29. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894-897. (Pubitemid 28410911)
30. Kaufman DW, Helmrich SP, Rosenberg L, Miettinen OS, Shapiro S. Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med. 1983;308:409-413. (Pubitemid 13191937)
31. Curfs DM, Knaapen AM, Pachen DM, Gijbels MJ, Lutgens E, Smook ML, Kockx MM, Daemen MJ, van Schooten FJ. Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB J. 2005;19: 1290-1292. (Pubitemid 41113726)
32. Ramos KS, Moorthy B. Bioactivation of polycyclic aromatic hydrocarbon carcinogens within the vascular wall: implications for human atherogenesis. Drug Metab Rev. 2005;37:595-610. (Pubitemid 43068150)
33. Thirman MJ, Albrecht JH, Krueger MA, Erickson RR, Cherwitz DL, Park SS, Gelboin HV, Holtzman JL. Induction of cytochrome cypia1 and formation of toxic metabolites of benzo(a)pyrene by rat aorta: a possible role in atherogenesis. Proc Natl Acad Sci USA. 1994;91:5397-5401. (Pubitemid 24174334)
34. Lecureur V, Ferrec EL, N-Diaye M, Vee ML, Gardyn C, Gilot D, Fardel O. Erk-dependent induction of TNFα expression by the environmental contaminant benzo(a)pyrene in primary human macrophages. FEBS Lett. 2005;579:1904-1910. (Pubitemid 40404029)
35. N Diaye M, Le Ferrec E, Lagadic-Gossmann D, Corre S, Gilot D, Lecureur V, Monteiro P, Rauch C, Galibert MD, Fardel O. Aryl hydrocarbon receptor-and calcium-dependent induction of the chemokine ccl1 by the environmental contaminant benzo(a)pyrene. J Biol Chem. 2006; 281:19906-19915. (Pubitemid 44065764)
36. McMillan BJ, Bradfield CA. The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc Natl Acad Sci USA. 2007; 104:1412-1417. (Pubitemid 46184018)
37. Arehart E, Giasson G, Walsh MT, Patterson H. Dioxin alters the human low-density and very low-density lipoprotein structure with evidence for specific quenching of Trp-48 in apolipoprotein C-II. Biochemistry. 2004; 43:8503-8509. (Pubitemid 38902528)
38. Yamaguchi Y, Matsuno S, Kagota S, Haginaka J, Kunitomo M. Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin. Atherosclerosis. 2004;172:259-265. (Pubitemid 38167536)
39. Santanam N, Sanchez R, Hendler S, Parthasarathy S. Aqueous extracts of cigarette smoke promote the oxidation of low density lipoprotein by peroxidases. FEBS Lett. 1997;414:549-551. (Pubitemid 27390665)
40. Yokode M, Ueyama K, Arai NH, Ueda Y, Kita T. Modification of highand low-density lipoproteins by cigarette smoke oxidants. Ann N Y Acad Sci. 1996;786:245-251. (Pubitemid 26273169)
41. Yokode M, Kita T, Arai H, Kawai C, Narumiya S, Fujiwara M. Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc Natl Acad Sci USA. 1988;85:2344-2348. (Pubitemid 24315888)